June 29, 2004 Corporate Partnerships with Universities and Patents DuPont's Oncomouse patent licensing program continues to cause a stir in academia and industry. Related Insights News Fenwick Recognized as Leading Patent Firm in IAM Patent 1000 June 9, 2026 News Fenwick Earns Top Rankings in Chambers USA 2026 June 4, 2026 Event AILBA Panel: International IP Strategy in the Age of AI May 20, 2026 Publication New USPTO Procedure Allows Patent Owners to Respond Before a Reexamination is Ordered April 13, 2026 News Fenwick Named Inaugural U.S. Firm of the Year at Managing IP’s Americas Awards April 10, 2026 Media Coverage Who Owns an AI-Assisted Invention? February 26, 2026 News Chambers Global 2026 Highlights Fenwick’s U.S. and Cross-Border Strength February 12, 2026 View more insights
Publication New USPTO Procedure Allows Patent Owners to Respond Before a Reexamination is Ordered April 13, 2026